首页> 外文期刊>Investigative ophthalmology & visual science >Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines
【24h】

Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines

机译:使用来自人类报告者多能干细胞系的3-D视网膜培养物治疗视网膜和黄斑疾病的范例

获取原文
获取外文期刊封面目录资料

摘要

We discuss the use of pluripotent stem cell lines carrying fluorescent reporters driven by retinal promoters to derive three-dimensional (3-D) retina in culture and how this system can be exploited for elucidating human retinal biology, creating disease models in a dish, and designing targeted drug screens for retinal and macular degeneration. Furthermore, we realize that stem cell investigations are labor-intensive and require extensive resources. To expedite scientific discovery by sharing of resources and to avoid duplication of efforts, we propose the formation of a Retinal Stem Cell Consortium. In the field of vision, such collaborative approaches have been enormously successful in elucidating genetic susceptibility associated with age-related macular degeneration.
机译:我们讨论了利用多能干细胞系携带由视网膜启动子驱动的荧光报告基因在培养物中获得三维(3-D)视网膜的方法,以及如何利用该系统阐明人类视网膜生物学,在培养皿中建立疾病模型,以及设计针对视网膜和黄斑变性的靶向药物筛选。此外,我们意识到干细胞研究是劳动密集型的,需要大量资源。为了通过共享资源来加快科学发现并避免重复工作,我们建议组建视网膜干细胞协会。在视觉领域,这种合作方法在阐明与年龄相关的黄斑变性相关的遗传易感性方面取得了巨大的成功。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号